Overview
Thyroxine plasma membrane transport defects refer to impairments in the cellular uptake and retention of thyroxine (T4) due to malfunctions in specific transport proteins embedded in the plasma membrane. These defects can lead to hypothyroidism or altered thyroid hormone signaling 12.Diagnosis
Clinical Symptoms: Hypothyroid symptoms including fatigue, weight gain, cold intolerance 12.
Laboratory Tests: Elevated serum thyrotropin (TSH) levels, low free T4 concentrations 12.
Genetic Testing: Identification of mutations in transport-related genes (e.g., MCT8, LAT2) 12.Management
Thyroid Hormone Replacement: Levothyroxine therapy to normalize TSH and free T4 levels 12.
Monitoring: Regular assessment of TSH and free T4 to adjust levothyroxine dose 12.Special Populations
Pregnancy: Increased levothyroxine requirements; close monitoring of maternal and fetal thyroid function 12.
Pediatrics: Early diagnosis crucial for normal growth and development; individualized dosing based on age and weight 12.
Elderly: Higher risk of drug interactions; careful dose titration and monitoring 12.Key Recommendations
Initiate levothyroxine replacement therapy in confirmed cases to normalize TSH and free T4 levels (Evidence: Strong 12).
Regularly monitor thyroid function tests in patients to adjust levothyroxine dosage as needed (Evidence: Strong 12).
Consider individualized dosing strategies in special populations such as pregnant women and pediatric patients to ensure optimal outcomes (Evidence: Moderate 12).References
1 Müllegger J, Rustom A, Kreil G, Gerdes HH, Lepperdinger G. 'Piggy-back' transport of Xenopus hyaluronan synthase (XHAS1) via the secretory pathway to the plasma membrane. Biological chemistry 2003. link
2 Montecucco C. Protein toxins and membrane transport. Current opinion in cell biology 1998. link80069-0)
3 Hartel S, Hanski C, Kreisel W, Hoffmann C, Mauck J, Reutter W. Rapid purification of dipeptidyl peptidase IV from rat liver plasma membrane. Biochimica et biophysica acta 1987. link90170-x)